EU Clears AbbVie Takeover of Allergan Subject to Conditions EU Clears AbbVie Takeover of Allergan Subject to Conditions

The European Commission said on Friday it had approved U.S. drugmaker AbbVie ' s planned $63 billion acquisition of Botox-maker Allergan, subject to conditions.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news